NGNE Neurogene Inc.
Healthcare$27.10-2.20%ClosedMarket Cap: $428.2M
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
94
13F Shares
16,506,555
Ownership %
78.0%
New Positions
14
Increased Positions
38
Closed Positions
9
Reduced Positions
30
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Virtus Biotech Clinical Trials ETF | 13,033 | 0.76% | |
| ALPS Medical Breakthroughs ETF | 12,606 | 0.21% | |
| State Street SPDR S&P Kensho New Economies Composite ETF | 101,075 | 0.09% | |
| 35,495 | 0.06% | ||
| iShares Micro-Cap ETF | 28,425 | 0.05% | |
| 28,425 | 0.05% | ||
| Fidelity Enhanced Small Cap ETF | 77,849 | 0.04% | |
| 96,438 | 0.02% | ||
| iShares Biotechnology ETF | 94,694 | 0.02% | |
| Avantis U.S. Small Cap Equity ETF | 17,531 | 0.02% | |
| iShares Russell 2000 Value ETF | 96,438 | 0.02% | |
| 270,461 | 0.01% | ||
| iShares Russell 2000 ETF | 270,461 | 0.01% | |
| 48,504 | 0.01% | ||
| 115,861 | 0.00% | ||
| 115,861 | 0.00% | ||
| 115,861 | 0.00% | ||
| 115,861 | 0.00% | ||
| Vanguard Total Stock Market ETF | 382,191 | 0.00% | |
| 382,191 | 0.00% |